Market Tracker

09/02 4:55am ET

Endocyte Inc (NASDAQ:ECYT)

7.36
Data as of Aug 29
 +0.3799 / +5.44%
Today’s Change
5.91
Today|||52-Week Range
33.70
-31.09%
Year-to-Date

Today’s Trading

Previous close6.98
Today’s open7.08
Day’s range-- - --
Volume2,090,999
Average volume (3 months)1,085,131
Market cap$305.8M
Dividend yield--
Data as of 08/29/2014

Growth & Valuation

Earnings growth (last year)-4.17%
Earnings growth (this year)+94.95%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.04%
P/E ratio27.3
Price/Sales5.93
Price/Book3.02

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.13+1.92%
SVASinovac Biotech Ltd+0.03+0.55%
ACRXAcelRx Pharmaceutica...+0.03+0.42%
RGLSRegulus Therapeutics...+0.08+1.18%
Data as of 08/29/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$64.9M
Annual profit (last year)-$18.0M
Net profit margin-27.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts